StockWatch
·

NORRIS MEDICINES LTD. Q3 FY26 Results

NORRISQ3 FY26 Results
Filing
MetricValue ( Cr)Q3 FY25
Revenue3.27195.3%
Total Income3.27194.6%
Expenditure2.5784.7%
PBT0.70347.3%
Net Profit0.70347.3%
OPM28.95%78.05pp
NPM21.35%46.78pp
EPS0.70350.0%
View full financials

Informational and educational content only. Not investment advice.